WebCompany profile for Oncternal Therapeutics Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ONCT description & address. WebMarket Holidays Daily Analyst Ratings Daily Insider Trading. Research Tools . ... Oncternal Therapeutics (ONCT) Stock Forecast & Price Target. Follow. 424 Followers. Portfolio. See the Price Targets and Ratings of: All Analysts. Top Analysts . Premium. ONCT Analyst Ratings. Hold. 5 Ratings. 0 Buy. 5 Hold.
ONCT: Oncternal Therapeutics - Insider Transations - Zacks.com
Web23. feb 2024. · Overview of insider trading in Oncternal Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications … WebOncternal Therapeutics Inc (NASDAQ:ONCT) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held ... black downspout diverter
ONCT Oncternal Therapeutics Inc. Company Profile & Executives
Web23. jul 2024. · Insider Purchases - Short Term Profit Analysis. In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Shanghai … WebInsider Trading Screener built from SEC ownership forms - Oncternal Therapeutics Inc. (ONCT) ... (ONCT) Split adjusted. Oncternal Therapeutics, Inc. Pharmaceutical … WebInsider Monkey. Mar-09-23 04:01PM: Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results. GlobeNewswire. ... It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T), which is in Phase 1/2 clinical trial for the treatment of hematologic malignancies and solid tumors ... black downspout extension